Kidney protection from two blood pressure and cholesterol pill combos
Part of Heart & circulation clinical trials.
This study tests whether two different blood pressure and cholesterol pill combinations can protect your kidneys. The two combinations are fimasartan plus atorvastatin, with or without an added medication called ezetimibe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high blood pressure and high cholesterol.
- Your doctor plans to start you on one of two pill combinations: either fimasartan plus atorvastatin, or fimasartan plus atorvastatin plus ezetimibe.
- You have not taken both fimasartan and atorvastatin together in the 4 weeks before the study starts.
- You have not taken part in another investigational drug study in the last 12 weeks (observational studies without a drug are okay).
- You agree to sign a consent form and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a single pill that combines two cholesterol-lowering medicines (pitavastatin and ezetimibe). It may be a good fit if you already take a statin or a statin plus ezetimibe and your doctor wants to adjust your treatment.
This study tests a new pill that combines two blood pressure medicines to see if it can lower blood pressure more effectively in people with moderate to severe high blood pressure. If you have high blood pressure that is not well controlled, this trial might help you find a new treatment option.
This trial studies whether fixed-dose blood pressure medicines—either two drugs (fimasartan + amlodipine) or three drugs (fimasartan + amlodipine + hydrochlorothiazide)—work well and are safe. It may help your care team compare how these combinations control blood pressure and what side effects occur.
This trial tests whether taking two experimental drugs together can safely lower both high blood pressure and high cholesterol. It may be an option if you have both conditions and your blood pressure is not extremely high.
This trial tests a combination pill of two cholesterol-lowering medicines (pitavastatin and ezetimibe) in adults who have been taking either atorvastatin or rosuvastatin for at least 3 months. It aims to see if switching to this new combination is safe and effective.
This trial tests whether taking a moderate-strength statin (cholesterol-lowering drug) plus ezetimibe (another cholesterol medicine) together helps protect the heart and kidneys in people who have both chronic kidney disease and established heart disease or stroke history.
Hear when a new Essential Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.